1 and 2 July 2025 | Design Offices München Macherei
The innovation spotlight is on! Ahead of BayOConnect 2025 this summer, the featured start-ups and poster presentations are now set. Explore what’s next in biotech, medtech, and healthtech — and get ready to meet the minds behind tomorrow’s breakthroughs.
This year’s poster exhibition highlights early and advanced-stage research from universities and hospitals, as well as young companies, covering new methods for AI-driven antibody RNA-targeting, high-throughput analytics, next-gen diagnostics, and predictive biotherapeutic development. The curated display offers a window into the scientific pulse of Bavaria’s life science landscape. Discover how machine learning, novel biophysical tools, and synthetic biology are shaping the future of biotech.
The Start-up Pitch Session will take place from 11:30 to 12:30 p.m. on the main stage. Selected founders will step into the spotlight to present their groundbreaking innovations live, which cover innovative approaches in gene therapy, immunotolerance, radioligand therapy, AI-driven immuno-oncology, non-invasive cancer diagnostics, RNA-targeting small molecules, CRISPR-based point-of-care testing, small molecule RNA targeting, and sustainable solutions in agriculture and apiculture.
Who’s going to grab this year’s BayOConnect Start-up Award?
The most impressive start-up team will receive one free ticket to the BIO-Europe on 3-5 November in Vienna, sponsored by EBD Group.
Pioneering ideas address important health issues
2NA FISH: What if we could precisely capture disease-relevant RNA- and unlock a new era in targeted ADC bladder cancer therapy?
Alithea Bio: How can the development of precise and safe immunotherapies be revolutionized by combining immunopeptidomics, mass spectrometry, and artificial intelligence?
Berking Therapeutics: How can next-generation radioligand therapies revolutionize cancer treatment by using ultra-specific nanobodies to deliver radioisotopes directly to tumor cells?
BioExoTec: How can a simple saliva or blood test save lives by detecting cancer before symptoms appear—faster, cheaper, and without invasive biopsies?
Leopard Biosciences: How can an 'upside-down CRISPR' platform that flips the traditional diagnostic paradigm enable ultra-sensitive, multiplex testing at the point of care — bringing lab-quality results to the front lines of healthcare and strengthening global pandemic preparedness?
MarkHerz: How can cardiovascular-specific AAV vectors unlock a new era of precision gene therapy for vascular and metabolic diseases — moving beyond one-size-fits-all solutions in Cell & Gene Therapy?
Toleris: How can a new class of off-the-shelf biologics inspired by pregnancy unlock durable, antigen-specific immune tolerance—treating autoimmune disease without suppressing the entire immune system?
Tuari Therapeutics: Can targeting the overlooked RAL pathway downstream of KRAS unlock a mutation-independent, resistance-free strategy to treat millions of cancer patients where current therapies fail?
Varolis: Can a single-dose, residue-free lithium-based treatment finally solve the global Varroa crisis—offering sustainable protection for honeybee colonies without resistance or labor-intensive application?
xFOREST: Can an AI-ready screening platform that tests billions of RNA-compound combinations finally unlock precision small molecule drugs for undruggable genes—transforming RNA into the next frontier in drug discovery?
Start-ups and posters are now online: Explore the next generation of life science innovation
The tension is over: the selected start-ups and scientific posters for our upcoming event are now available online. Discover the most promising innovations and emerging ventures shaping the future of biotechnology and medicine.
Ready to discover?
<link https: www.bayoconnect.org hauptmenue poster-presentations.html _new>Explore the posters and start-ups
Listen to the pitches live: <link https: www.bayoconnect.org hauptmenue tickets.html>Register now to attend BayOConnect 2025